|
EIF4EBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
3.21030000027811E-07 |
| Normal-vs-Stage3 |
1.9220000002651E-07 |
| Normal-vs-Stage4 |
1.84932999999221E-05 |
| Stage1-vs-Stage2 |
5.006400E-01 |
| Stage1-vs-Stage3 |
6.342400E-01 |
| Stage1-vs-Stage4 |
8.214800E-01 |
| Stage2-vs-Stage3 |
8.625000E-01 |
| Stage2-vs-Stage4 |
5.234400E-01 |
| Stage3-vs-Stage4 |
6.818000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
6.99107438606461E-13 |
| Normal-vs-Asian |
1.497350E-03 |
| Caucasian-vs-AfricanAmerican |
7.071000E-01 |
| Caucasian-vs-Asian |
9.221800E-01 |
| AfricanAmerican-vs-Asian |
8.803800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
8.40119973588571E-10 |
| Male-vs-Female |
2.709000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.79809500622241E-11 |
| Normal-vs-Extreme_Weight |
6.4627192486455E-12 |
| Normal-vs-Obese |
1.50940038246006E-10 |
| Normal-vs-Extreme_Obese |
1.80759999999225E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.405000E-01 |
| Normal_Weight-vs-Obese |
1.129400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.876400E-01 |
| Extreme_Weight-vs-Obese |
6.178700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.337000E-01 |
| Obese-vs-Extreme_Obese |
5.760800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.42530000002417E-06 |
| Normal-vs-Age(41-60Yrs) |
1.88959958791202E-13 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
1.08889999994588E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.338200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.468800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.653400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.442000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.179200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.532400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.99990090733149E-11 |
| Normal-VS-Type2 PRCC |
8.00490007613064E-10 |
| Normal-VS-KIRP CIMP |
3.52770000000557E-05 |
| Normal-VS-Unclassified PRCC |
2.46509999999311E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.813150E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.932400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.068000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.870600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.672400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.480400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.41050521157626E-11 |
| Normal-vs-N1 |
7.70029999763722E-08 |
| Normal-vs-N2 |
3.578600E-04 |
| N0-vs-N1 |
9.178800E-01 |
| N0-vs-N2 |
3.644600E-01 |
| N1-vs-N2 |
3.722000E-01 |
|
|
